Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Neuroblastoma 22Central Nervous System Neoplasms 9Sarcoma 7Lymphoma 7Wilms Tumor 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Medulloblastoma 5Astrocytoma 5Rhabdomyosarcoma 4Retinoblastoma 4Recurrence 4Leukemia 4Dendritic Cell Sarcoma, Interdigitating 4Brain Neoplasms 4Testicular Neoplasms 3Sarcoma, Ewing 3Rhabdoid Tumor 3Optic Nerve Glioma 3Hepatoblastoma 3Ganglioneuroblastoma 3Familial ependymoma 3Carcinoma, Renal Cell 3Burkitt Lymphoma 3Oligodendroglioma 2Neoplasms, Germ Cell and Embryonal 2Myelodysplastic Syndromes 2Meningeal Carcinomatosis 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chromosome Aberrations × Busulfan × CNS × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡